Who Owns Nautilus Biotechnology Stock?
NASDAQ: NAUTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 34.59%
- Held by insiders
- 31.99%
- Institutional holders
- 124
- Institutions 34.6%
- Insiders 32.0%
- Public and other 33.4%
Who owns Nautilus Biotechnology stock?
Institutional investors own about 34.6% of Nautilus Biotechnology's shares, spread across 124 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 31.99% of NAUT.
The largest institutional holders are Perceptive Advisors Llc (9.08%), Cercano Management Llc (5.63%) and Blackrock Inc. (2.45%). Together, the top 10 institutions control 27.8% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their NAUT positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NAUT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Perceptive Advisors Llc | 11.56M | 9.08% | -0.6% |
| Cercano Management Llc | 7.17M | 5.63% | 0.0% |
| Blackrock Inc. | 3.13M | 2.45% | +16.4% |
| a16z Capital Management, L.L.C. | 2.66M | 2.09% | -70.7% |
| Vanguard Capital Management LLC | 2.55M | 2.00% | 0.0% |
| Comprehensive Financial Management, LLC | 2.21M | 1.73% | 0.0% |
| Acadian Asset Management. LLC | 2.13M | 1.67% | +102.0% |
| Renaissance Technologies, LLC | 1.62M | 1.27% | +134.3% |
| Geode Capital Management, LLC | 1.40M | 1.10% | +11.0% |
| JPMORGAN CHASE & CO | 977.31K | 0.77% | +59.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NAUT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.93M | 1.52% |
| iShares Trust-iShares Russell 2000 ETF | 1.34M | 1.05% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 557.21K | 0.44% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 543.26K | 0.43% |
| iShares Trust-iShares Russell 2000 Value ETF | 535.57K | 0.42% |
| JPMorgan Trust II-JPMorgan Small Cap Value Fund | 332.89K | 0.26% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 286.37K | 0.22% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 274.78K | 0.22% |
| iShares Trust-iShares Micro-Cap ETF | 182.47K | 0.14% |
| VALIC Co I-Small Cap Value Fund | 123.73K | 0.10% |
Frequently asked questions
Who is the largest shareholder of Nautilus Biotechnology?
Perceptive Advisors Llc is the largest institutional shareholder of NAUT, owning 9.08% of shares outstanding (11.56M shares) as of its latest 13F filing.
What percentage of Nautilus Biotechnology is owned by institutions?
Institutions own about 34.6% of NAUT shares and 50.9% of the public float.
How much of Nautilus Biotechnology do insiders own?
Insiders, such as officers and directors, own about 31.99% of NAUT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.